Benchmarking Sustainability Goals: Pharmaceutical Companies

Benchmarking Sustainability Goals: Pharmaceutical Companies $300.00

This report provides a quantitative analysis of the sustainability goals of pharmaceutical industry leaders Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi and Teva.

Goals signal intent and drive behavior. Some companies use public announcements of sustainability goals to signal their commitment to become sustainability leaders and to compete for superior positioning with their rivals. There has never been a convenient benchmarking  tool to allow sustainability executives to put their own goals in the context of their competitors. Until now.


Purchase this report to learn:

  • How do the pharma companies' environmental sustainability goals compare?
  • Which sustainability issues are receiving the greatest attention?
  • Which companies are setting the most quantitative, forward-looking goals?
  • And more.

Pages: 11; Figures: 5

Outline

Key Questions
Key Finding
Goals and Targets Drive Change and Competitive Differentiation
Major Pharmas’ Goals Are Focused on Operations
Few Goals Deal with Supply Chain or Biodiversity
Wide Disparity in Number of Goals and Target Years
GHG Emissions and Energy Receive the Most Focus
List of Goals
Sources
Methodology
Related Research

Figures

Figure 1 Breakdown of Sustainability Goals by Major Area
Figure 2 GSK's carbon footprint in 2009 (% of CO2e)
Figure 3 Number of Sustainability Goals per Company by Target Year
Figure 4 Percentage of Goals Addressing Each Issue
Figure 5 List of Company Sustainability Goals
Categories
All Research
Benchmarking
Free Research
Most Popular
Recent Research
Sustainability Management
Tools and Technologies




Questions?
Contact us:
info [at] greenresearch.com
+1 646-783-8337